Metropolis Healthcare has announced a board meeting scheduled for February 04, 2026, to consider and approve the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The board will also consider the issuance of bonus shares, subject to shareholder approval. The trading window is closed from January 01, 2026, to February 06, 2026.
Board Meeting Announcement
A meeting of the Board of Directors of Metropolis Healthcare is scheduled for Wednesday, February 04, 2026. The meeting will address key financial and corporate matters.
Financial Results Review
The board will consider and approve the un-audited standalone and consolidated financial results for the quarter and nine months, which concluded on December 31, 2025. This review will provide insights into the company’s financial performance during the specified period.
Potential Bonus Share Issuance
The Board will also be evaluating the possibility of issuing bonus shares. This consideration is subject to applicable provisions and requires the approval of the company’s shareholders.
Trading Window Closure
In compliance with the company’s code of conduct for insider trading prevention, the trading window is currently closed. This restriction began on January 01, 2026, and will remain in effect until February 06, 2026 (inclusive of both days). This closure restricts trading in the company’s securities for designated individuals.
Source: BSE
